Skip to main content
Year archive

Genscript Biotech Corporation — 2023 filings

All 101 regulatory filings released by Genscript Biotech Corporation (1548) in 2023, sourced directly from the official regulator.

101 Filings
2023 Period
2023 filings (101)
Filing Released Lang
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES U.S. LABEL UPDATE FOR CARVYKTI
Regulatory Filings
2023-12-21 English
INSIDE INFORMATION: COMPLETION OF ACQUISITION OF SHARES BY A SUBSTANTIAL SHAREHOLDER FROM A CONTROLLING SHAREHOLDER
Regulatory Filings
2023-12-19 English
INSIDE INFORMATION: ACQUISITION OF SHARES BY A SUBSTANTIAL SHAREHOLDER FROM A CONTROLLING SHAREHOLDER AND UNDERTAKING OF NON-DECREASE OF SHAREHOLDING FOR ONE YEAR BY A CONTROLLING SHAREHOLDER
Regulatory Filings
2023-12-12 English
VOLUNTARY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES PRESENTATIONS AT THE 2023 ASH ANNUAL MEETING
Regulatory Filings
2023-12-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Regulatory Filings
2023-12-06 English
Next Day Disclosure Return
Regulatory Filings
2023-12-01 English
GRANT OF RESTRICTED SHARES
Regulatory Filings
2023-11-28 English
Next Day Disclosure Return
Regulatory Filings
2023-11-28 English
Next Day Disclosure Return
Regulatory Filings
2023-11-26 English
Next Day Disclosure Return
Regulatory Filings
2023-11-23 English
OVERSEAS REGULATORY ANNOUNCEMENT - UNAUDITED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED 30 SEPTEMBER 2023 BY A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
Regulatory Filings
2023-11-20 English
Next Day Disclosure Return
Regulatory Filings
2023-11-13 English
INSIDE INFORMATION AND OVERSEAS REGULATORY ANNOUNCEMENT: ENTERING INTO THE EXCLUSIVE GLOBAL LICENSING AGREEMENT BETWEEN LEGEND BIOTECH AND NOVARTIS
Regulatory Filings
2023-11-13 English
Next Day Disclosure Return
Regulatory Filings
2023-11-08 English
Next Day Disclosure Return
Regulatory Filings
2023-11-07 English
Next Day Disclosure Return
Regulatory Filings
2023-11-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
Regulatory Filings
2023-11-06 English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2023-11-02 English
VOLUNTARY ANNOUNCEMENT: PRELIMINARY SALES FOR CARVYKTI FOR THE QUARTER ENDED 30 SEPTEMBER 2023
Regulatory Filings
2023-10-17 English
Next Day Disclosure Return
Regulatory Filings
2023-10-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
Regulatory Filings
2023-10-08 English
NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REQUEST FORM - NOTICE OF PUBLICATION OF 2023 INTERIM REPORT
Regulatory Filings
2023-09-26 English
NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND CHANGE REQUEST FORM - NOTICE OF PUBLICATION OF 2023 INTERIM REPORT
Regulatory Filings
2023-09-26 English
INTERIM REPORT 2023
Regulatory Filings
2023-09-26 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING
Regulatory Filings
2023-09-25 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
Regulatory Filings
2023-09-05 English
Next Day Disclosure Return
Regulatory Filings
2023-09-01 English
GRANT OF RESTRICTED SHARES
Regulatory Filings
2023-08-24 English
OVERSEAS REGULATORY ANNOUNCEMENT: NOTICE OF ANNUAL GENERAL MEETING OF LEGEND BIOTECH CORPORATION
Regulatory Filings
2023-08-22 English
ANNOUNCEMENT OF UNAUDITED CONSOLIDATED INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2023
Regulatory Filings
2023-08-20 English
INSIDE INFORMATION AND OVERSEAS REGULATORY ANNOUNCEMENT: (1) UNAUDITED FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED 30 JUNE 2023 BY A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION AND (2) ACHIEVING
Regulatory Filings
2023-08-15 English
ANNOUNCEMENT PURSUANT TO RULES 13.51B(2) AND 13.51(2) OF THE LISTING RULES
Regulatory Filings
2023-08-11 English
DATE OF BOARD MEETING
Regulatory Filings
2023-08-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
Regulatory Filings
2023-08-04 English
VOLUNTARY ANNOUNCEMENT: PRELIMINARY SALES FOR CARVYKTI FOR THE QUARTER ENDED 30 JUNE 2023
Regulatory Filings
2023-07-20 English
INSIDE INFORMATION: BUSINESS UPDATE OF THE NON-CELL THERAPY BUSINESS FOR THE SIX MONTHS ENDED 30 JUNE 2023
Regulatory Filings
2023-07-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Regulatory Filings
2023-07-05 English
INSIDE INFORMATION COMPLETION OF THE BSJ CAPITAL INCREASE
Regulatory Filings
2023-06-25 English
SUPPLEMENTAL ANNOUNCEMENT TO THE GRANT OF RESTRICTED SHARES
Regulatory Filings
2023-06-15 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES SUBMISSION OF SUPPLEMENTAL APPLICATION TO U.S. FDA FOR EXPANDED USE OF CARVYKTI
Regulatory Filings
2023-06-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
Regulatory Filings
2023-06-06 English
LEGEND BIOTECH ANNOUNCES RESULTS FROM PHASE 3 CARTITUDE-4 STUDY
Regulatory Filings
2023-06-06 English
GRANT OF RESTRICTED SHARES
Regulatory Filings
2023-06-01 English
Next Day Disclosure Return
Regulatory Filings
2023-05-29 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Regulatory Filings
2023-05-29 English
Risk Management and ESG Committee - Terms of Reference
Regulatory Filings
2023-05-29 English
INSIDE INFORMATION: DEEMED DISPOSAL OF EQUITY INTEREST IN BSJ NANJING IN RELATION TO THE BSJ CAPITAL INCREASE
Regulatory Filings
2023-05-28 English
INSIDE INFORMATION: DEEMED DISPOSAL OF EQUITY INTEREST IN BSJ NANJING IN RELATION TO THE BSJ CAPITAL INCREASE
Regulatory Filings
2023-05-28 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES SUBMISSION TO THE EMA FOR EXPANDED USE OF CARVYKTI
Regulatory Filings
2023-05-25 English
THIRD AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Regulatory Filings
2023-05-25 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 25 MAY 2023
Regulatory Filings
2023-05-25 English
DISCLOSEABLE TRANSACTION: DEEMED DISPOSAL OF EQUITY INTEREST IN LEGEND BIOTECH
Regulatory Filings
2023-05-21 English
OVERSEAS REGULATORY ANNOUNCEMENT - UNAUDITED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED 31 MARCH 2023 BY A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
Regulatory Filings
2023-05-18 English
Next Day Disclosure Return
Regulatory Filings
2023-05-18 English
VOLUNTARY ANNOUNCEMENT: RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2023-05-16 English
EXERCISE OF LEGEND WARRANT BY WARRANTHOLDER AND OVERSEAS REGULATORY ANNOUNCEMENT
Regulatory Filings
2023-05-14 English
COMPLETION OF THE REGISTERED DIRECT OFFERING OF LEGEND BIOTECH
Regulatory Filings
2023-05-12 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES REGISTERED DIRECT OFFERING
Regulatory Filings
2023-05-08 English
DISCLOSEABLE TRANSACTION: DEEMED DISPOSAL OF EQUITY INTEREST IN LEGEND BIOTECH IN RELATION TO THE REGISTERED DIRECT OFFERING
Regulatory Filings
2023-05-08 English
DISCLOSEABLE TRANSACTION: DEEMED DISPOSAL OF EQUITY INTEREST IN LEGEND BIOTECH
Regulatory Filings
2023-05-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
Regulatory Filings
2023-05-07 English
NOTIFICATION LETTER TO NON-REGISTERED HOLDERS AND REQUEST FORM - NOTICE OF PUBLICATION CIRCULAR, NOTICE AND FORM OF PROXY FOR 2023 ANNUAL GENERAL MEETING
Regulatory Filings
2023-05-02 English
NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND CHANGE REQUEST FORM - NOTICE OF PUBLICATION CIRCULAR, NOTICE AND FORM OF PROXY FOR 2023 ANNUAL GENERAL MEETING
Regulatory Filings
2023-05-02 English
FORM OF PROXY FOR 2023 ANNUAL GENERAL MEETING
Regulatory Filings
2023-05-02 English
PROPOSALS FOR GRANTING OF GENERAL MANDATES TO ISSUE NEW SHARES AND TO REPURCHASE SHARES, RE-ELECTION OF RETIRING DIRECTORS, AMENDMENT OF MEMORANDUM AND ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GEN
Regulatory Filings
2023-05-02 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2023-05-02 English
NOTIFICATION LETTER TO NON-REGISTERED HOLDERS AND REQUEST FORM - NOTICE OF PUBLICATION OF 2022 ANNUAL REPORT
Regulatory Filings
2023-04-28 English
NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND CHANGE REQUEST FORM - NOTICE OF PUBLICATION OF 2022 ANNUAL REPORT
Regulatory Filings
2023-04-28 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2022
Regulatory Filings
2023-04-28 English
ANNUAL REPORT 2022
Regulatory Filings
2023-04-28 English
COMPLETION OF THE DISCLOSEABLE TRANSACTION IN RELATION TO THE DEEMED DISPOSAL OF EQUITY INTEREST IN LEGEND BIOTECH IN RELATION TO THE PRIVATE PLACEMENT
Regulatory Filings
2023-04-25 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES DISCLOSURES OF CLINICAL STUDY ABSTRACTS BY EHA
Regulatory Filings
2023-04-21 English
ADDITIONAL COMPLETION OF THE DEEMED DISPOSAL OF EQUITY INTEREST IN PROBIO CAYMAN
Regulatory Filings
2023-04-21 English
DISCLOSEABLE TRANSACTION DEEMED DISPOSAL OF EQUITY INTEREST IN LEGEND BIOTECH AND OVERSEAS REGULATORY ANNOUNCEMENT
Regulatory Filings
2023-04-20 English
VOLUNTARY ANNOUNCEMENT: PRELIMINARY SALES FOR CARVYKTI FOR THE QUARTER ENDED 31 March 2023
Regulatory Filings
2023-04-18 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022
Regulatory Filings
2023-04-14 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES SERVICE AGREEMENT WITH NOVARTIS
Regulatory Filings
2023-04-14 English
PROPOSED ADOPTION OF THE AMENDED MEMORANDUM AND ARTICLES OF ASSOCIATION
Regulatory Filings
2023-04-06 English
GRANT OF RESTRICTED SHARES
Regulatory Filings
2023-04-03 English
NEXT DAY DISCLOSURE RETURN
Regulatory Filings
2023-04-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
Regulatory Filings
2023-04-03 English
OVERSEAS REGULATORY ANNOUNCEMENT: RESULTS FOR THE YEAR ENDED 31 DECEMBER 2022 OF A LISTED SUBSIDIARY LEGEND BIOTECH CORPORATION
Regulatory Filings
2023-03-31 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022
Regulatory Filings
2023-03-31 English
OVERSEAS REGULATORY ANNOUNCEMENT ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2022 OF A LISTED SUBSIDIARY - LEGEND BIOTECH CORPORATION
Regulatory Filings
2023-03-30 English
NEXT DAY DISCLOSURE RETURN
Regulatory Filings
2023-03-29 English
DATE OF BOARD MEETING
Regulatory Filings
2023-03-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
Regulatory Filings
2023-03-03 English
SUPPLEMENTAL ANNOUNCEMENT TO THE INSIDE INFORMATION AND OVERSEAS REGULATORY ANNOUNCEMENT: UPDATE ON RESTATEMENT OF FINANCIAL STATEMENTS OF LEGEND BIOTECH
Regulatory Filings
2023-03-01 English
VOLUNTARY ANNOUNCEMENT: LEGEND BIOTECH REGAINS COMPLIANCE WITH NASDAQ LISTING RULE
Regulatory Filings
2023-02-23 English
VOLUNTARY ANNOUNCEMENT: LEGEND BIOTECH REGAINS COMPLIANCE WITH NASDAQ LISTING RULE
Regulatory Filings
2023-02-21 English
OVERSEAS REGULATORY ANNOUNCEMENT: FINANCIAL RESULTS FOR THE SECOND QUARTER AND HALF YEAR ENDED 30 JUNE 2022 OF A LISTED SUBSIDIARY LEGEND BIOTECH CORPORATION
Regulatory Filings
2023-02-19 English
INSIDE INFORMATION AND OVERSEAS REGULATORY ANNOUNCEMENT: UPDATE ON RESTATEMENT OF FINANCIAL STATEMENTS OF LEGEND BIOTECH
Regulatory Filings
2023-02-19 English
(1) INITIAL COMPLETION OF THE DEEMED DISPOSAL OF EQUITY INTEREST IN PROBIO CAYMAN (2) COMPLETION OF THE PURCHASE BY THE COMPANY
Regulatory Filings
2023-02-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
Regulatory Filings
2023-02-06 English
VOLUNTARY ANNOUNCEMENT: RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2023-01-27 English
VOLUNTARY ANNOUNCEMENT: PRELIMINARY SALES FOR CARVYKTI FOR THE QUARTER ENDED 31 DECEMBER 2022
Regulatory Filings
2023-01-25 English
GRANT OF RESTRICTED SHARES
Regulatory Filings
2023-01-18 English
INSIDE INFORMATION: (1) DEEMED DISPOSAL OF EQUITY INTEREST IN PROBIO CAYMAN (2) PURCHASE BY THE COMPANY
Regulatory Filings
2023-01-17 English
OVERSEAS REGULATORY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES NOTIFICATION OF DELINQUENCY FROM THE NASDAQ STOCK MARKET LLC
Regulatory Filings
2023-01-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
Regulatory Filings
2023-01-04 English
VOLUNTARY ANNOUNCEMENT: RESEARCH AND DEVELOPMENT UPDATE
Regulatory Filings
2023-01-02 English